Premenstrual Syndrome Therapeutic Pipeline Review H1 2015 Market Research Report at ReportsnReports.com
Dallas, TX (PRWEB) January 31, 2015 -- The report "Premenstrual Syndrome - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Premenstrual Syndrome. The premenstrual syndrome is a condition in women where certain symptoms occur each month before a period. Premenstrual syndrome often includes both physical and emotional symptoms include acne, swollen or tender breasts, feeling tired, trouble sleeping, upset stomach or diarrhea, headache or backache, appetite changes or food cravings, joint or muscle pain, trouble with concentration or memory, tension, irritability, mood swings, anxiety or depression. Complete Report is Available @ http://www.reportsnreports.com/reports/328723-premenstrual-syndrome-pipeline-review-h1-2015.html .
It also reviews key players involved in the therapeutic development for premenstrual syndrome and special features on late-stage and discontinued projects. Companies discussed in this Premenstrual Syndrome Pipeline Review H1 2015 report include DEKK-TEC, Inc., M et P Pharma AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB.
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=328723 . (This is a premium report priced at US$2000 for a single user License.)
Featured News & Press Releases
• Sep 19, 2014: Umecrine Mood announces positive results from an exploratory Phase I/II study with UC1010 in premenstrual dysphoric disorder (PMDD)
• Dec 16, 2013: Patient recruitment completed in the Phase I/II study of Umecrine Mood’s candidate drug for severe premenstrual symptoms
• May 23, 2013: Umecrine Mood Announces Dosing Of First Patient In Phase I/II Study Of UC1010 For Premenstrual Dysphoric Disorder
Table of Contents
List of Tables
Number of Products under Development for Premenstrual Syndrome, H1 2015 7
Number of Products under Development for Premenstrual Syndrome - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Premenstrual Syndrome - Pipeline by DEKK-TEC, Inc., H1 2015 14
Premenstrual Syndrome - Pipeline by M et P Pharma AG, H1 2015 15
Premenstrual Syndrome - Pipeline by Pherin Pharmaceuticals, Inc., H1 2015 16
Premenstrual Syndrome - Pipeline by Umecrine Mood AB, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 25
Premenstrual Syndrome Therapeutics - Recent Pipeline Updates, H1 2015 33
Premenstrual Syndrome - Dormant Projects, H1 2015 34
Inquiry Before Buying @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=328723 . (This is a premium report priced at US$2000 for a single user License.)
List of Figures
Number of Products under Development for Premenstrual Syndrome, H1 2015 7
Number of Products under Development for Premenstrual Syndrome - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 19
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Molecule Types, H1 2015 25
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, DeepResearchReports.com, http://www.deepresearchreports.com/, +1 (888) 391-5441, [email protected]
Share this article